XML 31 R6.htm IDEA: XBRL DOCUMENT v3.25.4
Consolidated Statements of Stockholders’ Equity - USD ($)
$ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Accumulated Deficit
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Other Comprehensive Loss
Beginning balance (in shares) at Dec. 31, 2022     191,447,000        
Beginning balance at Dec. 31, 2022 $ 906,693 $ (1,309) $ 2 $ 1,489,935 $ (573,046) $ (1,309) $ (10,198)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of common stock for Employee Stock Purchase Plan (in shares)     550,000        
Issuance of common stock for Employee Stock Purchase Plan 3,550     3,550      
Common stock issued upon vesting of restricted stock units (in shares)     1,335,000        
Stock-based compensation 25,559     25,559      
Stock option exercises (in shares)     482,000        
Stock option exercises 2,603     2,603      
Repurchase and retirement of common stock (in shares)     (6,880,000)        
Repurchase and retirement of common stock (67,621)     (67,621)      
Foreign currency translation gain, net 2,181           2,181
Net income (loss) (45,620)       (45,620)    
Ending balance (in shares) at Dec. 31, 2023     186,934,000        
Ending balance at Dec. 31, 2023 826,036   $ 2 1,454,026 (619,975)   (8,017)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of common stock for Employee Stock Purchase Plan (in shares)     409,000        
Issuance of common stock for Employee Stock Purchase Plan 3,310     3,310      
Common stock issued upon vesting of restricted stock units, net of shares withheld for employee taxes (in shares)     1,437,000        
Common stock issued upon vesting of restricted stock units, net of shares withheld for employee taxes (3,824)     (3,824)      
Stock-based compensation 26,491     26,491      
Stock option exercises (in shares)     653,000        
Stock option exercises 4,112     4,112      
Repurchase and retirement of common stock (in shares)     (5,708,000)        
Repurchase and retirement of common stock (57,909)     (57,909)      
Foreign currency translation gain, net (6,301)            
Foreign currency translation loss, net (7,298)           (7,298)
Disposition of Fitness Solutions 997           997
Net income (loss) $ (41,089)       (41,089)    
Ending balance (in shares) at Dec. 31, 2024 183,725,236   183,725,000        
Ending balance at Dec. 31, 2024 $ 750,826   $ 2 1,426,206 (661,064)   (14,318)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of common stock for Employee Stock Purchase Plan (in shares)     383,000        
Issuance of common stock for Employee Stock Purchase Plan $ 3,036     3,036      
Common stock issued upon vesting of restricted stock units (in shares) 1,955,000            
Common stock issued upon vesting of restricted stock units, net of shares withheld for employee taxes (in shares)     1,274,000        
Common stock issued upon vesting of restricted stock units, net of shares withheld for employee taxes $ (6,722)     (6,722)      
Stock-based compensation $ 28,429     28,429      
Stock option exercises (in shares) 954,000   953,000        
Stock option exercises $ 7,712     7,712      
Repurchase and retirement of common stock (in shares) (8,200,000)   (8,223,000)        
Repurchase and retirement of common stock $ (85,639)     (85,639)      
Foreign currency translation gain, net 1,632           1,632
Net income (loss) $ 17,599       17,599    
Ending balance (in shares) at Dec. 31, 2025 178,111,971   178,112,000        
Ending balance at Dec. 31, 2025 $ 716,873   $ 2 $ 1,373,022 $ (643,465)   $ (12,686)